Cencora, Inc. (COR)
NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 4 signals for Cencora, Inc.. Most notable: 2026-08-14: Filed 8-K disclosing director or officer change; 2026-09-25: Filed 8-K disclosing director or officer change; 2026-08-05: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $504,665. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleCampbell Elizabeth S (officer) sold $3.7M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Insider purchaseTyler Lauren M (director) bought $149k of stock
- Insider purchaseDURCAN DERMOT MARK (director) bought $1.1M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseDURCAN DERMOT MARK (director) bought $1.1M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleMauch Robert P. (director) sold $1.4M of stock
- Large insider saleMauch Robert P. (director) sold $1.4M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleMauch Robert P. (director) sold $1.8M of stock
- Large insider saleMauch Robert P. (director) sold $1.8M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleCampbell Elizabeth S (officer) sold $1.1M of stock
- Large insider saleMauch Robert P. (director) sold $1.8M of stock
- Large insider saleMauch Robert P. (director) sold $1.8M of stock
- Large insider saleKrikorian Lazarus (officer) sold $1.4M of stock
- Large insider saleMauch Robert P. (director) sold $1.9M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-01 | Krikorian Lazarus | officer | S | 986 | 303.18 | $298,935 |
| 2026-10-01 | SANCHEZ ROBERT E | director | A | 275 | — | — |
| 2026-09-16 | GREENBERG LON R | director | S | 1,280 | 321.3 | $411,264 |
| 2026-09-01 | Krikorian Lazarus | officer | S | 985 | 325.97 | $321,080 |
| 2026-08-24 | Campbell Elizabeth S | officer | S | 11,300 | 324.12 | $3,662,663 |
| 2026-07-31 | NALLY DENNIS M | director | A | 113 | 311.34 | $35,181 |
| 2026-07-31 | Cooper Ellen | director | A | 97 | 311.34 | $30,200 |
| 2026-07-31 | Tyler Lauren M | director | A | 97 | 311.34 | $30,200 |
| 2026-06-30 | Battaglia Silvana | officer | A | 58 | 240.53 | $14,000 |
| 2026-06-30 | Campbell Elizabeth S | officer | A | 50 | 240.53 | $12,000 |
| 2026-06-22 | Tyler Lauren M | director | P | 550 | 270.23 | $148,627 |
| 2026-06-22 | Tyler Lauren M | director | P | 550 | 270.23 | $148,627 |
| 2026-06-18 | DURCAN DERMOT MARK | director | P | 4,000 | 274.19 | $1,096,760 |
| 2026-06-18 | DURCAN DERMOT MARK | director | P | 4,000 | 274.19 | $1,096,760 |
| 2026-05-28 | DURCAN DERMOT MARK | director | P | 4,000 | 266.26 | $1,065,040 |
| 2026-05-28 | DURCAN DERMOT MARK | director | P | 4,000 | 266.26 | $1,065,040 |
| 2026-05-01 | Tyler Lauren M | director | A | 99 | 304 | $30,096 |
| 2026-05-01 | Cooper Ellen | director | A | 99 | 304 | $30,096 |
| 2026-05-01 | NALLY DENNIS M | director | A | 116 | 304 | $35,264 |
| 2026-05-01 | Tyler Lauren M | director | A | 99 | 304 | $30,096 |
| 2026-05-01 | Cooper Ellen | director | A | 99 | 304 | $30,096 |
| 2026-05-01 | NALLY DENNIS M | director | A | 116 | 304 | $35,264 |
| 2026-03-11 | Battaglia Silvana | officer | F | 3,673 | 350.3 | $1,286,652 |
| 2026-03-11 | Battaglia Silvana | officer | M | 8,415 | 0 | $0 |
| 2026-03-11 | Campbell Elizabeth S | officer | M | 12,623 | 0 | $0 |
| 2026-03-11 | Campbell Elizabeth S | officer | F | 5,842 | 350.3 | $2,046,453 |
| 2026-03-11 | Cleary James F | officer | M | 12,623 | 0 | $0 |
| 2026-03-11 | Cleary James F | officer | F | 5,409 | 350.3 | $1,894,773 |
| 2026-03-11 | Battaglia Silvana | officer | M | 8,415 | 0 | $0 |
| 2026-03-11 | Battaglia Silvana | officer | F | 3,673 | 350.3 | $1,286,652 |
| 2026-03-11 | Campbell Elizabeth S | officer | M | 12,623 | 0 | $0 |
| 2026-03-11 | Campbell Elizabeth S | officer | F | 5,842 | 350.3 | $2,046,453 |
| 2026-03-11 | Cleary James F | officer | M | 12,623 | 0 | $0 |
| 2026-03-11 | Cleary James F | officer | F | 5,409 | 350.3 | $1,894,773 |
| 2026-03-05 | NALLY DENNIS M | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Cooper Ellen | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Tyler Lauren M | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Baumann Werner | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Clyburn Frank | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | DURCAN DERMOT MARK | director | A | 905 | 359.28 | $325,148 |
| 2026-03-05 | GREENBERG LON R | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Kim Lorence H. | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Miller Redonda | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Ryerkerk Lori | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Cooper Ellen | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | NALLY DENNIS M | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Tyler Lauren M | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Baumann Werner | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | Clyburn Frank | director | A | 557 | 359.28 | $200,119 |
| 2026-03-05 | DURCAN DERMOT MARK | director | A | 905 | 359.28 | $325,148 |
Federal contracts
24-month federal obligations: $504,665
- 2026-10-20 $351,357 · Department of Veterans Affairs · PAPZIMEOS IMMUNOTHERAPY
- 2026-10-13 $74,529 · Department of Veterans Affairs · EMERGENT PROCURMENT OF DIGOXIN IMMUNE FAB FOR WESTERN NY VA PHARMACY.
- 2026-09-25 $46,019 · Department of Veterans Affairs · EMERGENCY ADSTILADRIN SUSP,INTRAVESIC (NDC 55566-1050-01)
- 2026-10-01 $32,760 · Department of Veterans Affairs · DIGIFAB
- 2026-10-08 $0 · Department of Veterans Affairs · IMPLEMENTING EO 14398 DEI DISCRIMINATION DIGIFAB
- 2026-10-27 $0 · Department of Veterans Affairs · IMPLEMENTING EO 14398 DEI DISCRIMINATION PAPZIMEOS IMMUNOTHERAPY
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 158 views/day vs 90-day median 202.